Saxenda Side Effects: Liraglutide Risks and User Reports
Saxenda side effects: liraglutide label warnings for weight management, GI effects, and how they relate to Victoza and Ozempic. Not medical advice.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Saxenda is liraglutide approved for chronic weight management. Victoza is liraglutide for type 2 diabetes. Side effects are mainly gastrointestinal (nausea, diarrhoea, constipation, vomiting), with serious label warnings in the GLP-1 class including pancreatitis, gallbladder disease, kidney problems from dehydration, and a boxed thyroid C-cell tumour warning from rodent data. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Saxenda vs newer weekly GLP-1s
Liraglutide is a daily injection; semaglutide and tirzepatide are weekly in their common brands. Many community accounts frame newer agents as producing more weight loss on average — see semaglutide vs liraglutide. Twin diabetes brand: Victoza side effects. Canada: Saxenda in Canada.
What users report
Liraglutide stories on this site are fewer than semaglutide or tirzepatide. Browse the liraglutide hub and compare GI themes on Ozempic side effects.
Related topics
related peptides:
community guides:
More confessions from the archive
Community Q&A
- What are common Saxenda side effects?
- Labels emphasise gastrointestinal effects: nausea, diarrhoea, constipation, vomiting and abdominal pain, especially early on.
- Is Saxenda the same as Victoza?
- Same active ingredient (liraglutide), different brands and labelled uses — weight management vs type 2 diabetes.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.